Grupo Farmaceutico SOMAR Competitors and Similar CompaniesClear all
Grupo Farmaceutico SOMAR's competitors and similar companies include Cadila Pharmaceuticals, Genentech, CSL Behring and Biogen.
 Grupo Farmaceutico SOMAR Grupo Farmacéutico SOMAR is a pharmaceutical company focused on the development, manufacture, and marketing of generic and branded generic products. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 1951 | Founding Date 1976 | Founding Date 1904 | Founding Date 1978 |
Type | Type Private | Type Private | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Ciudad de México, MX HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | |
Employees | Employees 339 | Employees 8,5201% increase | Employees 18,077 | Employees 7,5692% decrease | Employees 7,605 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) |
Operating ⚠ | |||||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 28 (Jul, 2025) | Phase I Trials Products N/A | Phase I Trials Products 4 (FY, 2024) |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 19 (Jul, 2025) | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2024) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 41 (Jul, 2025) | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Cadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company